113 related articles for article (PubMed ID: 21709491)
1. 131I activity in urine to the sewer system due to thyroidal treatments.
Andrés C; Barquero R; Tortosa R; Nuñez C; del Castillo A; Vega-Carrillo HR; Alonso D
Health Phys; 2011 Aug; 101 Suppl 2():S110-5. PubMed ID: 21709491
[TBL] [Abstract][Full Text] [Related]
2. Liquid discharges from patients undergoing 131I treatments.
Barquero R; Basurto F; Nuñez C; Esteban R
J Environ Radioact; 2008 Oct; 99(10):1530-4. PubMed ID: 18243440
[TBL] [Abstract][Full Text] [Related]
3. Radioactivity in municipal sewage and sludge.
Martin JE; Fenner FD
Public Health Rep; 1997; 112(4):308-16; discussion 317-8. PubMed ID: 9258296
[TBL] [Abstract][Full Text] [Related]
4. [Intravenous or oral 131I treatment of hyperthyroidism and thyroid cancer?].
Müller KD; Grebe SF; Bock FL; Müller H; Fängewisch GL
Nuklearmedizin; 1994 Jun; 33(3):87-92. PubMed ID: 8090631
[TBL] [Abstract][Full Text] [Related]
5. Estimated dose rates to members of the public from external exposure to patients with 131I thyroid treatment.
Dewji S; Bellamy M; Hertel N; Leggett R; Sherbini S; Saba M; Eckerman K
Med Phys; 2015 Apr; 42(4):1851-7. PubMed ID: 25832075
[TBL] [Abstract][Full Text] [Related]
6. Iodine-131 in sewage sludge from a small water pollution control plant serving a thyroid cancer treatment facility.
Rose PS; Swanson RL
Health Phys; 2013 Aug; 105(2):115-20. PubMed ID: 23799495
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75.
Coover LR; Silberstein EB; Kuhn PJ; Graves MW
J Nucl Med; 2000 Nov; 41(11):1868-75. PubMed ID: 11079497
[TBL] [Abstract][Full Text] [Related]
8. The use of delay tanks in the management of radioactive waste from thyroid therapy.
Goddard C
Nucl Med Commun; 1999 Jan; 20(1):85-94. PubMed ID: 9949417
[TBL] [Abstract][Full Text] [Related]
9. Correlation between external exposure and activity in patients undergoing 131I thyroid cancer therapy.
Barquero R; Basurto F; Vega-Carrillo HR; Iñiguez MP; Ferrer N; Esteban R
Health Phys; 2008 Aug; 95(2):227-33. PubMed ID: 18617804
[TBL] [Abstract][Full Text] [Related]
10. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
[TBL] [Abstract][Full Text] [Related]
11. [A proposal to improve radioactive waste disposal following metabolic radio-iodine therapy].
Bekier A
Strahlentherapie; 1975 May; 149(5):499-503. PubMed ID: 1154447
[TBL] [Abstract][Full Text] [Related]
12. 131I ablation treatment in young females after the Chernobyl accident.
Travis CC; Stabin MG
J Nucl Med; 2006 Oct; 47(10):1723-7. PubMed ID: 17015910
[TBL] [Abstract][Full Text] [Related]
13. Collecting system for radioactive excreta from patients.
van der Giessen PH; Bierhuizen H
Strahlentherapie; 1980 Apr; 156(4):275-6. PubMed ID: 7368236
[TBL] [Abstract][Full Text] [Related]
14. [Problems with radiation protection for adjuvant radiotherapy of thyroid cancer].
Siekierzyński M
Wiad Lek; 2001; 54 Suppl 1():307-11. PubMed ID: 12182040
[TBL] [Abstract][Full Text] [Related]
15. Hospital discharge of patients with thyroid carcinoma treated with 131I.
Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
[TBL] [Abstract][Full Text] [Related]
16. Radioprotection using iodine-131 for thyroid cancer and hyperthyroidism: a review.
Al-Shakhrah IA
Clin J Oncol Nurs; 2008 Dec; 12(6):905-12. PubMed ID: 19064384
[TBL] [Abstract][Full Text] [Related]
17. Iodine-131 contamination from thyroid cancer patients.
Ibis E; Wilson CR; Collier BD; Akansel G; Isitman AT; Yoss RG
J Nucl Med; 1992 Dec; 33(12):2110-5. PubMed ID: 1460501
[TBL] [Abstract][Full Text] [Related]
18. [Environmental radiation exposure of a thyroid cancer patient resulting from adjuvant iodine radiotherapy].
Chaś J; Kowalczyk A; Siekierzyński M; Dziuk E; Janiak MK
Wiad Lek; 2001; 54 Suppl 1():312-20. PubMed ID: 12182042
[TBL] [Abstract][Full Text] [Related]
19. A retrospective study on the transition of radiation dose rate and iodine distribution in patients with I-131-treated well-differentiated thyroid cancer to improve bed control shorten isolation periods.
Yama N; Sakata K; Hyodoh H; Tamakawa M; Hareyama M
Ann Nucl Med; 2012 Jun; 26(5):390-6. PubMed ID: 22382609
[TBL] [Abstract][Full Text] [Related]
20. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
